Astrazeneca (AZN) Non Operating Interest Expenses (2009 - 2026)
Astrazeneca's Non Operating Interest Expenses came in at -$477 million for Q3 2026, compared with -$434 million a year earlier.
Powered by 
Analysis
Astrazeneca (AZN) Non Operating Interest Expenses (2009 - 2026) Analysis & Trends
Over the trailing twelve months to Sep 30, 2026, Astrazeneca reported Non Operating Interest Expenses of -$919 million; for FY2025, it came in at $1.69 billion, down 2.8% from FY2024.
- Non Operating Interest Expenses carries a five-year compound annual growth rate of 5.3% (FY2020 to FY2025).
- Going back by year, Non Operating Interest Expenses was $1.74 billion in FY2024 (+7.1%), $1.63 billion in FY2023 (+20.8%), $1.35 billion in FY2022 (+3.5%) and $1.3 billion in FY2021 (-0.5%).
- The five-year range for quarterly Non Operating Interest Expenses is -$484 million (Q4 2025) to $443 million (Q2 2024).
- Business Quant data shows AZN's Non Operating Interest Expenses at $435 million (Q2 2026), -$393 million (Q1 2026) and -$484 million (Q4 2025) in the three quarters before Q3 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Operating Interest Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,359.75 Bn | 1,333.37 Bn | 20.46 Bn | - |
| 2 | Johnson & Johnson | 688.76 Bn | 608.62 Bn | 17.30 Bn | 217.00 Mn |
| 3 | AbbVie | 521.69 Bn | 489.75 Bn | 13.12 Bn | - |
| 4 | Merck | 364.31 Bn | 327.31 Bn | 13.19 Bn | - |
| 5 | Novartis Ag | 306.35 Bn | 279.93 Bn | - | - |
| 6 | Astrazeneca | 285.96 Bn | 259.56 Bn | 13.26 Bn | -477.00 Mn |
| 7 | Amgen | 251.88 Bn | 203.53 Bn | 7.58 Bn | 653.00 Mn |
| 8 | Gilead Sciences | 208.59 Bn | 183.61 Bn | 6.73 Bn | 269.00 Mn |
| 9 | Pfizer | 164.73 Bn | 112.38 Bn | 12.56 Bn | - |
| 10 | Vertex Pharmaceuticals | 136.55 Bn | 104.28 Bn | 2.91 Bn | 36.00 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | -477.00 Mn |
| Jun 30, 2026 | 435.00 Mn |
| Mar 31, 2026 | -393.00 Mn |
| Dec 31, 2025 | -484.00 Mn |
| Sep 30, 2025 | -434.00 Mn |
| Jun 30, 2025 | 439.00 Mn |
| Mar 31, 2025 | -349.00 Mn |
| Dec 31, 2024 | -429.00 Mn |
| Sep 30, 2024 | -457.00 Mn |
| Jun 30, 2024 | 443.00 Mn |
| Mar 31, 2024 | -413.00 Mn |
| Dec 31, 2023 | -445.00 Mn |
| Sep 30, 2023 | -392.00 Mn |
| Jun 30, 2023 | 431.00 Mn |
| Mar 31, 2023 | -365.00 Mn |
| Dec 31, 2022 | -360.00 Mn |
| Sep 30, 2022 | -339.00 Mn |
| Jun 30, 2022 | 311.00 Mn |
| Mar 31, 2022 | -336.00 Mn |
| Dec 31, 2021 | -336.00 Mn |
API Access
Astrazeneca Non Operating Interest Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-operating-interest-expenses&ticker=AZN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-operating-interest-expenses", "ticker": "AZN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-operating-interest-expenses&ticker=AZN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();